These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Current status and perspectives of individualized therapy for non-small cell lung cancer based on molecular targeting]. Shi YK Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):398-400. PubMed ID: 22883466 [No Abstract] [Full Text] [Related]
3. [Is chemotherapy still an option in oncogene-addicted non-small cell lung cancer? No]. Girard N Bull Cancer; 2015 Jun; 102(6 Suppl 1):S96-9. PubMed ID: 26118885 [TBL] [Abstract][Full Text] [Related]
5. Gefitinib in the treatment of advanced non-small-cell lung cancer. Reck M Expert Rev Anticancer Ther; 2009 Apr; 9(4):401-12. PubMed ID: 19374595 [TBL] [Abstract][Full Text] [Related]
6. [CRAF, a key player in lung adenocarcinomas induced by K-Ras oncogene]. Francoz S; Dubus P Med Sci (Paris); 2011 Oct; 27(10):820-2. PubMed ID: 22027418 [No Abstract] [Full Text] [Related]
7. Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer. Mu XL; Li LY; Zhang XT; Wang MZ; Feng RE; Cui QC; Zhou HS; Guo BQ Clin Cancer Res; 2005 Jun; 11(12):4289-94. PubMed ID: 15958609 [TBL] [Abstract][Full Text] [Related]
8. PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine. Pilotto S; Peretti U; Novello S; Rossi G; Milella M; Giaj Levra M; Ciuffreda L; Massari F; Brunelli M; Tortora G; Bria E Expert Opin Pharmacother; 2013 Apr; 14(5):597-608. PubMed ID: 23472711 [TBL] [Abstract][Full Text] [Related]
10. More than just an oncogene translocation and a kinase inhibitor: Kevin's story. Costa DB J Clin Oncol; 2012 Jan; 30(1):110-2. PubMed ID: 22067391 [No Abstract] [Full Text] [Related]
11. Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive. Santarpia M; Altavilla G; Salazar MF; Magri I; Pettineo G; Benecchi S; Rosell R Expert Rev Respir Med; 2011 Jun; 5(3):413-24. PubMed ID: 21702662 [TBL] [Abstract][Full Text] [Related]
12. Using EGFR status to personalize treatment: lung cancer researchers reach a milestone. Friedrich MJ J Natl Cancer Inst; 2009 Aug; 101(15):1039-41. PubMed ID: 19638503 [No Abstract] [Full Text] [Related]